Why NovoCure Stock Is Surging Today
After the company posted upbeat second-quarter results, shares of NovoCure (NASDAQ: NVCR), a medical device company focused on oncology, rose as much as 10% in afternoon trading on Thursday. Shares were up about 9% as of 2:55 p.m. EDT.
Here are the headline numbers from the second quarter:
Image source: Getty Images.
Quelle Fool.com


